ClinConnect ClinConnect Logo
Search / Trial NCT05599139

Iodine Uptake After a Low Iodine Diet

Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Oct 25, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Low Iodine Diet Iodine Uptake

ClinConnect Summary

This clinical trial is studying how a low iodine diet (LID) affects the way the thyroid absorbs iodine in patients with differentiated thyroid cancer (DTC). Specifically, the researchers want to see the difference in iodine uptake before and after participants follow a 7-day low iodine diet, using a low dose of radioactive iodine for measurement. This information is important because it helps doctors understand how effective the diet is in preparing patients for further treatment, such as radioactive iodine therapy.

To participate in this trial, individuals must be at least 18 years old, diagnosed with differentiated thyroid cancer, and able to follow the study guidelines. They also need to be able to understand Dutch. Some people may not be eligible, such as those under 18, those taking certain medications, or those with kidney problems. If you join the study, you can expect to follow the low iodine diet for a week and then have your iodine uptake measured before and after this diet. This research is currently recruiting participants and aims to gather valuable insights for better treatment strategies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients, men and women above the age of 18 years, have to be diagnosed with DTC and have to follow a LID prior to the 131I ablation therapy according to the Dutch DTC guideline
  • Patients have to be fit to adhere to the study protocol
  • Patients have to be able to read and understand the Dutch language
  • Exclusion Criteria:
  • Age \< 18 years
  • Patients using amiodarone
  • Patients receiving iodinated contrast \< 3 months before the LID
  • Pregnancy
  • Patients prepared for ablation therapy with rhTSH
  • Renal impairment, EGFR \<30ml/min/1,73m2

About University Medical Center Groningen

University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.

Locations

Groningen, , Netherlands

Patients applied

0 patients applied

Trial Officials

Wouter Zandee, Dr.

Principal Investigator

University Medical Center Groningen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials